Leaflet MOLSIHEXAL 4mg tablets
Indicated for: angina pectoris
Route of administration: oral
Substance: molsidomine (nitrate vasodilator)
ATC: C01DX12 (Cardiovascular system | Vasodilators used in cardiac diseases | Other vasodilators used in cardiac diseases)
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Molsidomine is a medication used for the prevention and treatment of angina pectoris (chest pain caused by reduced blood flow to the heart). It belongs to the class of nitric oxide donors, which help relax blood vessels, reducing the workload on the heart and improving blood flow.
It is primarily used for the prevention of angina attacks but is not suitable for treating acute episodes. Molsidomine is often prescribed as maintenance therapy for patients with coronary artery disease.
Side effects may include headaches, dizziness, low blood pressure, or, more rarely, nausea. Patients should follow the prescribed dosage and avoid abrupt discontinuation of the treatment.
Molsidomine is contraindicated in cases of severe hypotension or cardiogenic shock and should be used with caution in patients with other cardiovascular conditions.
General data about MOLSIHEXAL 4mg
- Substance: molsidomine
- Date of latest medicines list: 01-07-2013
- Product code: W12574001
- Concentration: 4mg
- Pharmaceutical form: tablets
- Quantity: 30
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for molsidomine
Concentrations available for molsidomine
- 1mg
- 4mg
- 8mg